Sleep disturbance and short sleep duration are associated with inflammation and related disorders including cardiovascular disease, arthritis, diabetes mellitus, and certain cancers. This study was undertaken to test the effects of experimental sleep loss on spontaneous cellular inflammation and activation of signal transducer and activator of transcription (STAT) family proteins, which together promote an inflammatory microenvironment. In 24 healthy adults (16 females; 8 males), spontaneous production of IL-6 and TNF-a in monocytes and spontaneous intranuclear expression of activated STAT1, STAT3, and STAT5 in peripheral blood mononuclear cells (PBMC), monocyte-, and lymphocyte populations were measured in the morning after uninterrupted baseline sleep, partial sleep deprivation (PSD, sleep period from 3 a.m. to 7 a.m.), and recovery sleep. Relative to baseline, spontaneous monocytic expression of IL-6 and TNF-a was significantly greater after PSD (P < 0.02) and after recovery sleep (P < 0.01). Relative to baseline, spontaneous monocytic expression of activated STAT1 and STAT5 was significantly greater after recovery sleep (P < 0.007 and P < 0.02, respectively) but not STAT3 (P = 0.09). No changes in STAT1, STAT3, or STAT5 were found in lymphocyte populations. Sleep loss induces activation of spontaneous cellular innate immunity and of STAT family proteins, which together map the dynamics of sleep loss on the molecular signaling pathways that regulate inflammatory and other immune responses. Treatments that target short sleep duration have the potential to constrain inflammation and reduce the risk for inflammatory disorders and some cancers in humans.
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Introduction
Insomnia complaints are associated with adverse health outcomes, including cardiovascular disease, certain cancers, and all cause mortality (Dew et al., 2003; Irwin, 2013 Irwin, , 2015 Li et al., 2014; Vgontzas et al., 2010) , and such health risks are further elevated among those who have both sleep disturbance and short sleep duration (Vgontzas et al., 2013) . Epidemiologic evidence further shows that a decrease in sleep duration over 6 years prospectively predicts a twofold increase in cardiovascular mortality 17 years later (Ferrie et al., 2007) . Given that activation of cellular signals that initiate expression of inflammatory cytokines and systemic inflammation is associated with risk of a wide spectrum of medical conditions including cardiovascular disease, certain cancers, and mortality (Baune et al., 2011; DiDonato et al., 2012; Karin, 2006; Reuben et al., 2002; Ridker et al., 2003; Volpato et al., 2001) , one of the most studied biological mechanisms underlying these observations is inflammation (Irwin, 2015) .
Insomnia complaints, as well as nonrestorative sleep, have been associated with increases in CRP and other markers of inflammation in epidemiologic (Laugsand et al., 2012; Liukkonen et al., 2007; Zhang et al., 2013 ), naturalistic observational (Bornivelli et al., 2008 Chiu et al., 2009; Okun et al., 2007 Okun et al., , 2009 , and clinical studies of patients with insomnia disorder (Razeghi et al., 2012; Vgontzas et al., 2002; Burgos et al., 2006 #12189), as reviewed (Irwin, 2015 . However poor sleep can also be due to the consequence of disease processes involving inflammation (Opp, 2009) , and the causal role of sleep loss on inflammation is not known from these cross-sectional data. One prospective epidemilogic study suggests that disturbances of sleep, as well as decreases in sleep duration, uniquely contribute to cellular markers of inflammation with increases in interleukin-6 (IL-6), for example (Ferrie et al., 2013) . Additionally, experimental sleep loss, such as partial night sleep deprivation (PSD) induces increases in C-reactive protein (CRP) (Meier-Ewert et al., 2004) and IL-6 (Haack et al., 2007; Vgontzas et al., 2004) , as well as increases in inflammatory transcripts of IL-1b, IL-6, and IL-17 (van Leeuwen et al., 2009), although 
